We are in a remarkable time in cancer medicine. The investment in cancer research over the past several decades has helped us in our understanding of the biology of malignant cells, and how such cells interact with their microenvironment, especially the immune system. We have learned that cancer is more complex at the molecular level more than we ever imagined.